SEC Form D · Amendment · filed September 23, 2014
VentiRx Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Kent M. Snyder · Seattle, WADirectorNicole M. Vitullo · Princeton, NJDirectorSteven M. Gillis, Ph.D · Seattle, WADirectorAtul M. Saran · Seattle, WADirectorKathleen M. Fanning · Seattle, WAExecRon M. Laufer · Gaithersburg, MDDirectorPatrick M. Heron · Seattle, WADirectorRobert M. Hershberg, M.D., Ph.D · Seattle, WAExec · DirectorChristopher J. Velis · Littleton, MADirectorJohn Cunningham · BELLEVUE, WADirectorTimothy M. Brown · Boston, MADirectorChris H. Ropko · GERMANTOWN, TNDirectorMark H. Ricketts · GERMANTOWN, TNDirectorCarlo Joseph · Atlanta, GAExecJohn F. Civantos · New York, NYExec · DirectorGpe Viii GP Aiv S.A.R.L · Boston, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗